tiprankstipranks
Trending News
More News >
Myriad Genetics (MYGN)
NASDAQ:MYGN

Myriad Genetics (MYGN) Revenue

Compare
429 Followers

Myriad Genetics Revenue

Myriad Genetics had a revenue of 209.80M in the quarter ending Dec 31, 2025, with 1.99%. This bring the company's revenue in the last twelve months to 824.50M, Increased -0.10%. In the fiscal year ending Dec 31, 2025, Myriad Genetics had annual revenue of 824.50M with -1.56% growth.
Revenue (ttm)
824.50M
Revenue Growth
0.21%
P/S Ratio
0.52
Revenue/Employee
$305,370
Employees
2,700
Market Cap
$428.27M

Revenue Chart

Revenue History
Fiscal End Date
Revenue
Change
Growth
Dec 31, 2025
824.50M-13.10M-1.56%
Dec 31, 2024
837.60M84.40M+11.21%
Dec 31, 2023
753.20M74.80M+11.03%
Dec 31, 2022
678.40M-12.20M-1.77%
Dec 31, 2021
690.60M133.60M+23.99%
Jun 30, 2020
557.00M-81.60M-12.78%
Jun 30, 2019
638.60M-134.00M-17.34%
Jun 30, 2018
772.60M-78.50M-9.22%
Jun 30, 2018
851.10M